Brorphine—Investigation and quantitation of a new potent synthetic opioid in forensic toxicology casework using liquid chromatography‐mass spectrometry
- 17 November 2020
- journal article
- research article
- Published by Wiley in Journal of Forensic Sciences
- Vol. 66 (2) , 664-676
Abstract
New synthetic opioids continue to appear as novel psychoactive substances (NPS) on illicit drug markets. Isotonitazene emerged in mid‐2019, becoming the most prevalent NPS opioid in the United States within a few months. Notification by the Drug Enforcement Administration of its intent to schedule isotonitazene in mid‐2020 led to its decline in popularity and replacement with a new NPS opioid: brorphine. Brorphine is a potent synthetic opioid, but little information was previously available regarding its toxicity or involvement in impairment and death. Our laboratory developed an assay for the identification and quantitative confirmation of brorphine using standard addition. Quantitative analysis was performed using liquid chromatography‐tandem mass spectrometry (LC‐MS/MS). In vitro and in vivo metabolism studies were performed using pooled human liver microsomes and authentic biological specimens, respectively, with analysis by liquid chromatography quadrupole time‐of‐flight mass spectrometry (LC‐QTOF‐MS). Brorphine was confirmed in 20 authentic forensic cases, commonly found in combination with fentanyl (100%) and flualprazolam (80%). The average concentration of brorphine in blood was 2.5 ± 3.1 ng/mL (median: 1.1 ng/mL, range: 0.1–10 ng/mL). The average concentration of brorphine in urine was 4.6 ± 7.6 ng/mL (median: 1.6 ng/mL, range: 0.2–23 ng/mL). The majority of cases originated from Midwestern states. Metabolism was verified to included N‐dealkylation and hydroxylation. Detailed case histories and autopsy findings are presented herein. The prevalence of brorphine continues to increase in the United States. Forensic scientists should remain aware of the ongoing emergence of new opioids, especially those outside a standard scope of toxicology testing.Keywords
This publication has 21 references indexed in Scilit:
- Analysis of Fentanyl and 18 Novel Fentanyl Analogs and Metabolites by LC–MS-MS, and report of Fatalities Associated with Methoxyacetylfentanyl and CyclopropylfentanylJournal of Analytical Toxicology, 2018
- Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive reviewNeuropharmacology, 2018
- Opioids in the Frame of New Psychoactive Substances Network: A Complex Pharmacological and Toxicological IssueCurrent Molecular Pharmacology, 2018
- Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An UpdateTherapeutic Drug Monitoring, 2018
- Observed Carfentanil Concentrations in 355 Blood Specimens from Forensic InvestigationsJournal of Analytical Toxicology, 2017
- Metabolism of novel opioid agonists U‐47700 and U‐49900 using human liver microsomes with confirmation in authentic urine specimens from drug usersDrug Testing and Analysis, 2017
- A review: Fentanyl and non-pharmaceutical fentanylsDrug and Alcohol Dependence, 2017
- Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC–MS-MS and Its Identification in a Drug-Related DeathJournal of Analytical Toxicology, 2016
- A Series of Forensic Toxicology and Drug Seizure Cases Involving Illicit Fentanyl Alone and in Combination with Heroin, Cocaine or Heroin and CocaineJournal of Analytical Toxicology, 2014
- Discovery of the First Potent and Selective Small Molecule Opioid Receptor-like (ORL1) Antagonist: 1-[(3R,4R)-1-Cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl- 1,3-dihydro-2H-benzimidazol-2-one (J-113397)Journal of Medicinal Chemistry, 1999